Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphentin Efficacy and Safety in Pediatric ADHD
NCT01239030Phase 3Completed
- Sponsor
- Rhodes Pharmaceuticals
- Start
- Nov 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Rhodes Pharmaceuticals. Started Nov 2010; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01239030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239030.